Fanconi anemia (FA) is a recessive genome instability syndrome characterized by heightened cellular sensitivity to DNA damage, aplastic anemia and cancer susceptibility. Leukemias and squamous cell carcinomas (SCCs) are the most predominant FA-associated cancers, with the latter exhibiting markedly early disease onset and aggressiveness. Although studies of hematopoietic cells derived from FA patients have provided much insight into bone marrow deficiencies and leukemogenesis, molecular transforming events in FA-deficient keratinocytes, which are the cell type of origin for SCC, are poorly understood. We describe here the growth and molecular properties of FANCA-deficient versus FANCA-corrected HPV E6/E7 immortalized keratinocytes in monolayer and organotypic epithelial raft culture. In response to DNA damage, FANCA-deficient patient-derived keratinocyte cultures displayed a G2/M phase arrest, senescence and apoptosis. Organotypic raft cultures exhibited DNA repair-associated defects with more 53BP1 foci and TdT-mediated dNTP nick end labeling-positive cells over their corrected counterparts. Interestingly, together with reduced rates of DNA damage, FA correction resulted in a marked decrease in epithelial thickness and the presence of fewer cell layers. The observed FANCA-mediated suppression of hyperplasia correlated with the detection of fewer cells transiting through the cell cycle in the absence of gross differentiation abnormalities or apoptotic differences. Importantly, the knockdown of either FANCA or FANCD2 in HPV-positive keratinocytes was sufficient for increasing epithelial hyperplasia. Our findings support a new role for FA pathways in the maintenance of differentiation-dependent cell cycle exit, with the implication that FA deficiencies may contribute to the high risk of FA patients for developing HPVassociated SCC.
Introduction
Fanconi anemia (FA) is a rare, recessive DNA instability syndrome and is usually diagnosed early in life on the basis of congenital abnormalities, progressive aplastic anemia, cellular hypersensitivity to DNA damage and a greatly increased risk of cancer. FA-associated anemia is often fatal and presents a median life expectancy of 20 years in the absence of a bone marrow transplant (Alter, 2003) . Thirteen FA complementation groups were identified by cell fusion experiments (Wang, 2007) and more recently by retroviral complementation of specific FA genes (Hanenberg et al., 2002; Chandra et al., 2005) . FA pathway functionality involves a high molecular weight nuclear core complex composed of Fanconi anemia proteins FANCA, B, C, G, E, F, G, L, M, FAAP24 and FAAP100 (Meetei et al., 2003a (Meetei et al., , 2005 Niedernhofer et al., 2005) . Complex activation in response to DNA damage or replication results in the monoubiquitination of FANCD2 (Garcia-Higuera et al., 2001; Timmers et al., 2001) and FANCI (Dorsman et al., 2007; Sims et al., 2007; Smogorzewska et al., 2007) , and their colocalization with FANCD1/BRCA2 (Howlett et al., 2002) , FANCN/PALB2 (Reid et al., 2006; Rahman et al., 2007) and FANCJ (BRIP1) (Bridge et al., 2005; Levitus et al., 2005) on sites of DNA repair. Complex activation then mediates DNA repair through poorly understood mechanisms that most likely include the BRAFT complex, as FA proteins are components of the larger BRAFT DNA repair complex containing Bloom's helicase, replication protein A and topoisomerase IIIa (Meetei et al., 2003b Research has focused mainly on the hematopoietic problems in FA patients, which can now be cured with a successful bone marrow transplant under optimal circumstances. However, FA patients who have undergone bone marrow transplants continue to be at high risk for developing solid tumors. Squamous cell carcinomas (SCCs) of the head and neck (HN), anogenital region and skin are the most commonly diagnosed solid tumors in FA patients (Kutler et al., 2003b) , supporting important and independent FA functions in human keratinocytes. A potential link between human papillomavirus (HPV) and FA (Kutler et al., 2003b , c)-although controversial (van Zeeburg et al., 2004 -is supported by a recent report showing accelerated chromosomal instability in HPV16 E7 oncogene-expressing, FA-deficient mouse embryo fibroblasts (Spardy et al., 2007) . FA deficiency may accelerate tumorigenesis by promoting genomic instability that cooperates with HPV-mediated inactivation of critical tumor suppressors. Examination of FA-specific keratinocyte phenotypes in premalignant cells, particularly in the context of the HPV oncogenes, is critical for a deeper understanding of SCC development in FA patients.
Keratinocytes are the cell type of origin for SCC, but only one report has described some of the phenotypic characteristics of FA patient-derived epithelial cancer cell lines (van Zeeburg et al., 2005) . On account of the fact that keratinocyte differentiation as a major barrier to cancer has already been overcome in such tumors, the use of the above cell lines has not provided insights into the consequences of FA inactivation in the context of differentiation. Here, we describe the culture, FA correction known as complementation and characterization of HPV18 E6/E7-immortalized keratinocytes derived from a FANCA patient skin biopsy. This system explores the role of FA in an oncogenically challenged, premalignant state, and within three-dimensional epithelium. FANCA deficiency in E6/E7-positive monolayer cells did not result in significant changes in proliferation or cell death under normal culture conditions. However, in response to DNA damaging agents, phenotypes similar to those described for hematopoietic and stromal cells were evident. These included the lack of FANCD2 monoubiquitination, cell cycle arrest and increased rates of cell death. Interestingly, under differentiating conditions, FANCA complementation decreased HPV associated hyperplasia in organotypic epithelial rafts in correlation with a decrease in the proliferative index. Notable differences in the localization of differentiation markers were not observed. Conversely, FANCA or FANCD2 knockdown in HPV-positive cells increased HPV-associated hyperplasia. Taken together, our data demonstrate that HPV-associated hyperplasia in FANCA mutant epithelium can be attenuated by the re-establishment of a functional FA pathway, and that the loss of FA pathways in HPV-positive keratinocytes inhibits differentiation-associated cell cycle withdrawal.
Results
FA patient-derived, HPV18 E6/E7-immortalized keratinocytes exhibit DNA damage phenotypes To determine the consequences of FA deficiency on epithelial growth and differentiation, we isolated and cultured keratinocytes from a skin biopsy of a FANCAdeficient patient. The cells were immortalized by retroviral transduction with an HPV18 E6/E7 expression vector, and then either complemented with a FANCAexpressing retroviral vector or transduced with a control vector expressing only enhanced green fluorescent protein (EGFP) . A pure population of GFP-positive cells was obtained following flow cytometric sorting, and phenotypic differences were analysed in the presence and absence of DNA-damaging agents. FAN-CA expression in the complemented cells was confirmed at the level of protein expression (Figure 1a , lanes 3 and 4). Defects similar to those reported for hematopoietic cells and fibroblasts (Tamary and Alter, 2007) were observed following treatment with the DNA-damaging agents hydroxyurea (HU) and melphalan ( Figure 1 ). These included defective monoubiquitination of FANCD2 ( Figure 1a ) and reduced FANCD2 nuclear foci ( Figure 1c ) following HU treatment, as well as the accumulation of cells with a G2/M content following melphalan treatment (Figure 1b) . Control staining was performed with gH2AX-specific antibodies (1C). Importantly, partial phenotypic complementation could be achieved for each phenotype through the reintroduction of the FANCA cDNA.
FANCA-deficient keratinocytes are hypersensitive to mitomycin C-induced cell death Analyses of complemented versus noncomplemented cells in the absence of DNA-damaging agents did not reveal elevated rates of cell cycle arrest or apoptosis in the FA-deficient cells (Figure 2a ). We next determined whether these same cells were hypersensitive to DNAdamaging agents similar to FA hematopoietic and stromal cells. Keratinocyte populations were treated with increasing doses of mitomycin C (MMC) and subjected to flow cytometry-based measurements of apoptosis using activated caspase 3 antibodies. As observed with immortalized, FA mutant hematopoietic cells and fibroblasts, FA-deficient keratinocytes were more susceptible to apoptosis following MMC treatment (Figure 2b ). In addition, cell treatment with 50 ng/ml MMC and staining for the detection of senescence-associated beta gal activity (SA-bGal) after 10 days revealed heightened susceptibility to senescence (Figure 2b , right panels). These data support a scenario whereby the steady-state growth of immortalized, FAdeficient keratinocytes is not significantly impacted under standard in vitro conditions, but is compromised through apoptosis and senescence in response to exogenous DNA damage induction. DNA damage in FANCA-deficient epithelium To determine whether the absence of a functional FA pathway is associated with increased accumulation of DNA damage in HPV-positive human epithelium, we used the FA-deficient and -complemented cultures for generation of organotypic rafts. Detection of FANCD2 foci in FANCA-expressing, but not -deficient rafts confirmed successful complementation in this system ( Figure 3a ). We next quantitated nuclear 53BP1 foci in FANCA-deficient versus FANCA-complemented rafts ( Figure 3b ). 53BP1 is a component of the DNA damage response and sensor of DNA double-strand breaks (Huyen et al., 2004) . The number of cells with detectable nuclear 53BP1 foci as well as the number of foci per nucleus were substantially increased in FANCA-deficient compared with FANCA-complemented rafts.
The observed overactivated 53BP1 response is most likely a consequence of intracellular accumulation of DNA damage in FA-deficient rafts. To further support this notion, we quantitated double-stranded DNA ends on FANCA-deficient and -complemented rafts by TdT-mediated dNTP nick end labeling (TUNEL) staining. In total, over 1100 nuclei were counted for each raft. Excluding enucleating cells in the cornified layer, we detected increased numbers of TUNELpositive cells in the FANCA-deficient rafts ( Figure 3c ). We conclude that the repair of baseline and/or E6/E7-induced DNA damage in keratinocytes involves FA pathways.
HPV E6/E7-associated hyperplasia is attenuated by FANCA complementation and FANCA loss in HPV-positive cells stimulates hyperplasia In addition to evidence of DNA damage suppression in Figure 3 , the FANCA-complemented raft exhibited decreased hyperplasia upon morphological comparison ( Figure 4 ). Hematoxylin-and-eosin staining showed increased raft thickness and the presence of additional spinous cell layers in the FANCA-deficient compared with the FANCA-complemented rafts. Similar phenotypes were noted in two additional, independently derived epithelial rafts obtained from the same cell populations (data not shown). Hyperplasia was reflected by increased numbers of nuclei in the suprabasal compartment. Closer morphological examination (a) FANCA-deficient and -complemented cells were subjected to cell cycle and apoptosis measurements under standard culture conditions as described in Materials and methods. (b) Cells were exposed to increasing doses of MMC and subjected to apoptosis analyses. The asterisk indicates a P-value of less than 0.05. Cells treated with 50 ng/ml MMC were stained for SA-bGal activity 10 days post-exposure and imaged.
revealed approximately equal numbers of dysplastic and dyskeratotic cells, most likely related to E6/E7 expression, in both rafts (data not shown). Epithelial differentiation and maturation properties were also similar as verified by comparable patterns of expression of the basal cell marker K14 and the suprabasal cell Figure 1 were used for the generation of organotypic raft cultures as described in Materials and methods. Rafts were fixed, embedded in paraffin and sectioned. (a and b) FANCD2 and 53BP1 staining was performed as follows: tissue sections were baked overnight, deparaffinized in xylene and dehydrated in 100% ethanol. After rehydration in a graded ethanol series, slides were washed in distilled dH 2 O, microwave-treated in 0.01 M sodium citrate (pH 6.0) for 10 min (53BP1) or 30 min (FANCD2) and rinsed in dH 2 O. For FANCD2 staining, sections were digested using pepsin. All sections were then washed in PBS and blocked in 10% normal donkey serum for 30 min at room temperature. Slides were incubated with either a polyclonal antibody against 53BP1 or FANCD2 followed by a Fluorescein isothiocyanate-or Rhodamine Red-conjugated secondary antibody. Nuclei were stained with 4,6-diamidino-2-phenylindole. One or two asterisks represent P-values of less than 0.05 or 0.01, respectively. (c) TdT-mediated dNTP nick end labeling (TUNEL) staining was performed as per the Roche In situ Cell Death Detection Kit, TMR Red instructions. TUNEL-positive nuclei below the parakeratotic compartment are indicated by arrows. Nuclei were counterstained with 4,6-diamidino-2-phenylindole.
marker K10 by immunofluorescence ( Figure 4a , bottom two panels). Detection of the adherens junction component E-cadherin revealed more E-cadherin-positive cell layers, most likely a reflection of increased raft thickness, in the FANCA-deficient epithelium. However, we did not note obvious E-cadherin mislocalization and/or expression at a single cell level, indicating similar cellcell contact properties in the FANCA-deficient versus complemented epithelium. A marked reduction in hyperplasia was also observed upon FANCA complementation of HPV16 episome-immortalized FA patient keratinocytes (Figure 4b ). Conversely, we detected an increase in hyperplasia following lentiviral knockdown of FANCA in HPV-positive normal human keratinocytes (NIKs) and subsequent raft generation (Figure 4c ), thus ruling out the possibility that clonal selection might have been associated with the observed differences between FANCA-deficient versus sufficient patientderived keratinocytes. We cannot fully exclude the possibility that increased hyperplasia is a consequence of subtle cellular adaptation to FA loss that was undetectable in 2D culture. However, if proliferative gains and epithelial hyperplasia are adaptive in nature, our data would support that they remain reversible through the re-instatement of functional FA pathways by complementation. Reduced rates of proliferation in FANCA-complemented epithelium We next determined directly whether reduced proliferation might be responsible for the suppression of hyperplasia by FANCA (Figure 5a ). Detection of the proliferation marker Ki67 in the HPV18 E6/E7-positive patient-derived rafts from Figure 4a revealed a decreased proliferative index in the FANCA-complemented compared with the FANCA-deficient rafts (Figure 5a ). Quantitation of Ki67-and BrdU-positive cells in the HPV16-immortalized rafts from Figure 4b revealed similar decreases in the number of cells transiting through the cell cycle following complementation. Immunofluorescence detection of activated caspase 3 did not reveal an increased apoptotic index in the FANCA-complemented rafts (data not shown). We concluded that increased proliferative rates were responsible for the hyperplastic differences in the FANCA-deficient compared with the FANCA-complemented rafts. To further confirm this notion and to determine whether FA complex formation rather than a FANCA-specific effect was responsible, HPV-positive NIKs were used for the lentiviral knockdown of FANCD2 (Figure 5b ). Cells were infected as described in Materials and methods, selected in puromycin and carried on feeders without obvious differences in cellular growth. Organotypic rafts were generated, and 10 mM BrdU was added 48 h before raft harvest. BrdU detection by immunofluorescence revealed increased proliferation in the FANCD2 knockdown rafts. Taken together, our data support the notion that FA pathway deficiency weakens control of differentiation-associated cell cycle exit and that increased hyperplasia in FAdeficient epithelium is reversible by FA correction.
Discussion
Our data support the notion that FA-deficient human keratinocytes-like hematopoietic and stromal cellsrespond to DNA damage by exaggerated cell death. However, clinical observations suggest that keratinocyte-specific differences, perhaps through differential adaptation, might also exist. Specifically, extreme radiosensitivity of FA mutant oropharyngeal epithelium is not shared by fibroblast cultures derived from the same patient (Marcou et al., 2001) . Such cell-type differences may influence the timing of disease manifestation in distinct organs: anemia and leukemia are often diagnosed early, whereas SCC development is generally not observed until later (Alter, 2003) . Significant insight into the role of FA proteins in hematopoietic cells and fibroblasts has emerged in the past years, but no information is available on the role of FA pathways in differentiating keratinocytes. In light of most likely keratinocyte-specific FA phenotypes and their importance to SCC development, we chose to examine effects of FANCA loss on epithelial cells using patient-derived, FANCA-deficient keratinocytes. 
FA deficiency stimulates HPV-associated SSC EE Hoskins et al
Primary cells from a FANCA-deficient patient biopsy were immortalized with the HPV18 E6/E7 oncogenes, which are well characterized for their ability to inhibit cellular tumor suppressor pathways and to cause chromosomal instability (Duensing and Munger, 2004) . Immortalized cells were subsequently complemented with FANCA by retroviral gene transfer. This culture system probed the effect of FANCA deficiency in the context of oncogenic challenge, but not in the primary state. The difficulty of culturing primary cutaneous keratinocytes from fresh specimens, both FA and normal, has so far precluded such analyses.
Extending the short cellular life span of post-natal skin keratinocytes through better culture conditions will be required before meaningful growth comparisons between cells from FA patients versus normal donors can be initiated. Whether similar FA-dependent phenotypes will be observed in primary patient-derived cells or in cells immortalized with other viral and cellular oncogenes remains to be determined in the future. However, E6/E7 immortalization is particularly relevant for these studies, as a link has been suggested between FA-and HPV-associated disease. Specifically, in one study, 84% of FA-associated SCCs were reported to contain (FANCD2sh) were verified by western blot analysis using equal amounts of protein, and used for the generation of organotypic rafts. Rafts were incubated with 10 mM BrdU 48 h before harvesting. Sections were used for the detection of BrdU-positive cells within the rafts. BrdU-positive cells were strikingly over-represented in the suprabasal, K14-negative, compartment and are denoted with white arrows. K14 staining is not shown. The asterisks indicate statistical significance with a P-value of less than 0.01.
genomic DNA from the high-risk human papillomaviruses compared with only 36% of SCCs in the general population (Kutler et al., 2003c) . A link between FA and HPV is further supported by a recent report on accelerated chromosomal instability in FA-deficient, HPV16 E7 oncogene-expressing cells (Spardy et al., 2007) . Importantly, HPV DNA was not detectable in a cohort of Dutch FA patients with head and neck SCCs (van Zeeburg et al., 2004 (van Zeeburg et al., , 2005 . Reconciling these findings will require more extensive epidemiological and molecular studies of FA SCC samples in a manner that considers geographical and technical differences between the above studies. Our studies uncover several specific defects in FANCA-deficient keratinocytes, which are similar to those described for FA hematopoietic and stromal cells. These relate to the known roles of FA genes in the maintenance of genome stability. Under standard monolayer culture conditions, FA status in the keratinocyte populations did not significantly affect steadystate cell growth (Figure 2a ). In contrast, typical hallmarks of FA-deficient hematopoietic and stromal cells were evident under conditions of exogenous DNA damage. These included a lack of FANCD2 monoubiquitination and focus formation, increased G2/M cell cycle arrest in response to melphalan and apoptosis and senescence induction in response to MMC. These phenotypes have already been used for the clinical diagnosis of FA mutations in various settings (Taniguchi and D'Andrea, 2006) and add to the reported finding that FA cancer cell lines exhibit sensitivity to cisplatin (van Zeeburg et al., 2005) . Hallmarks of DNA damage further extended to FA-deficient three-dimensional epithelium as evidenced by 53BP1 and TUNEL positivity (Figure 3) . Taken together, similar to immortalized hematopoietic and stromal cells, keratinocytes require a functional FA pathway under conditions of genotoxic stress.
The HPV oncogenes are well known to mediate unscheduled reentry of differentiated cells into S phase and resulting hyperplasia, but their presence does not inhibit full execution of the cellular differentiation program. Uncoupling cell cycle exit from differentiation provides optimal replication conditions for the virus (Longworth and Laimins, 2004) . HPV18 E6/E7-associated hyperplasia in FA-deficient epithelium was observed as expected and, importantly, could be significantly attenuated by the reintroduction of FANCA expression (Figure 4a) . Similarly, HPV16-associated cellular hyperplasia was attenuated by complementation ( Figure 4b ). Taken together, these data suggest that FA complementation may be a useful approach for the treatment of high-risk HPV-positive lesions and may apply to lesions that maintain episomal HPV DNA. The observed differences between FA mutant and complemented epithelia correlated with decreased proliferative rates in a small subpopulation of cells within the suprabasal compartment. Conversely, FANCD2 knockdown in an HPV genome-positive immortalized keratinocyte cell line increased the proliferative index ( Figure 5) , thus supporting the hypothesis that FA deficiency stimulates hyperplasia in differentiated epithelium. Increased numbers of proliferating cells in FANCA and FANCD2 knockdown rafts would appear to implicate core complex-rather than FANCA-specific functions. Importantly, proliferative differences that are described in Figure 5 are observed only in a 3D context, and represent a small proportion of the raft compared with the vast excess of differentiated cells. It is therefore not surprising that the underlying biochemical mechanisms are not yet known. However, as some of the known cellular targets of E7, including the Rb pocket proteins and p21, represent critical links between cellular differentiation and cell cycle control, these molecules might be considered as possible candidate mediators for FA-dependent cell cycle control.
Relatively subtle abnormalities within FA-deficient epithelium as observed would explain the clinical lack of obvious skin defects, yet a high risk of SCC, in FA patients. The fact that FA complementation can inhibit E6/E7-driven hyperplasia suggests that intact FA functions can serve as a barrier to E6/E7-stimulated cell cycle abnormalities. It will be important to determine whether somatic FA mutations may be selected for during HPV SCC development in the general population. The loss of such functions in the FA patient population may explain the up to one thousand fold increased risk for developing SCC (Kutler et al., 2003b) , and we suggest that the pursuit of FA gene correction for the treatment of FA SCC might be a worthwhile clinical endeavor in the future. Taken together, our findings point to a novel role for the FA pathway in suppressing viral oncogene-induced cellular abnormalities.
Squamous cell carcinomas in FA patients presents at a particularly early age, generally with aggressive disease course and poor prognosis (Kutler et al., 2003a) : surgical treatment remains the mainstay, but relapsefree, 2-year survival rates are below 50%. Short-term toxicity following the radiotherapy of FA patientsboth as a conditioning regimen and as a treatment for SCC-has been noted in bystander epithelium (Alter, 2002) . Our in vitro studies confirm at a molecular level that FA-deficient cells and epithelium exhibit hypersensitivity to DNA damage induction (Figures 2 and 3) . Subsequent formation of secondary cancers within the same area of FA patients has overshadowed the initial success of the above-mentioned patient treatments (Bremer et al., 2003; Guardiola et al., 2004) and was perhaps due to the selection of surviving clones in an environment of genomic instability. We suggest that the hyperplastic phenotype in FA-deficient epithelium (Figure 4 ) might represent a clinically relevant precursor to SCC. Continued studies of this model will explore the underlying molecular pathways involved in SCC progression and will provide a foundation for the preclinical testing of new therapies. FA is a rare genetic disease; however, somatic inactivation of the FA pathway has been widely observed in sporadic cancers (Mathew, 2006) . In this way, the above-mentioned model system is also expected to advance our understanding of FAdeficient SCC in the general population.
Materials and methods

Cell culture and vectors
Fresh skin biopsies were obtained through the Fanconi Anemia Comprehensive Care Center from patients undergoing clinically indicated bone marrow aspiration, and keratinocytes were cultured on irradiated J2-3T3 feeder cells as described by Nakahara et al. (2005) . After colony outgrowth and replating, primary keratinocytes were transduced with the human papillomavirus type 18 E6 and E7 oncogenes by infection with the SF91-18E6/E7 retroviral vector, or transfected with episomal HPV16 DNA as described previously for primary normal keratinocytes (Hoskins et al., 2008) . The SF91 viral backbone was a generous gift from the Baum laboratory (Schambach et al., 2000) . For generation of the retroviral vector, the HPV18 E6/E7 open-reading form was cloned into pGEM Easy (Promega, Madison, WI, USA), excised using NotI and subcloned into NotI-digested pSF91 vector. Proper insert orientation was verified by PCR and the resulting vector was sequenced. E6/E7-and HPV-immortalized cells were carried for 12 passages to ensure relative culture stability, and then complemented with either FANCA-expressing retrovirus or with empty vector backbone. These vectors were described previously (Chandra et al., 2005) and were provided by the CCHMC Viral Vector Core and Translational Trials Development and Support Lab. A pure population of GFP-positive cells was obtained by flow cytometric sorting in the CCHMC Flow Core Facility.
FANCA and FANCD2-specific RNA interference HPV-positive NIKs were a gift from Paul Lambert, University of Wisconsin-Madison, and were carried as described previously (Nakahara et al., 2005) . Irradiated J2-3T3 cells were used as feeder cells. Nontargeting, FANCA and FANCD2-specific shRNA-expressing and puromycin-resistant lentiviral vectors were obtained through the Sigma MISSION shRNA program (Sigma-Aldrich, St Louis, MO, USA). Relevant product numbers were SHC 002V for the nontargeting control vector (NT), TRCN0000082841 for the FANCD2sh4 targeting vector and TRCN0000118982 and TRCN0000118985 for the FANCA-targeting vectors. Keratinocytes were infected with either lentiviral nontargeting control vector or with the FANCD2 shRNA expression vectors and selected in 1 mg/ ml puromycin for 4 days. For FANCA knockdown, five vectors were prescreened for functionality in HeLa cells overexpressing FANCA, and the two most potent vectors were selected, combined and used for the HPV-NIKs transduction. Successful FANCA knockdown was confirmed functionally by western blot detection of the mono-versus nonubiquitinated FANCD2 forms following cell exposure to HU for 16 h.
Organotypic epithelial raft culture Organotypic rafts were generated as described by Nakahara et al. (2005) . Briefly, a total of 1 Â 10 6 human keratinocytes was plated on a collagen matrix with embedded feeder fibroblasts. Exposure to the liquid-air interface resulted in the generation of stratified epithelium with differentiation properties that reflect its natural human counterpart. The tissue was fixed in 4% paraformaldehyde 12 days after lifting, embedded in paraffin, sectioned and morphologically examined by hematoxylin-and-eosin staining.
Immunofluorescence
Monolayer cultures Keratinocytes were plated onto polylysine-coated coverslips and allowed to grow at 37 1C and 5% CO 2 . When the cells reached 80% confluency, they were either left untreated or treated with 0.5 mM HU for 16 h to induce DNA damage. Keratinocytes were then extracted for 35 min on ice in supplemented CSK buffer (10 mM PIPES, 100 mm NaCl, 300 mM sucrose, 1 mM MgCl 2 , 1 mM ethylene glycol bis(aˆ-aminoethylether)-N,N,N 0 ,N 0 ,-tetraacetic acid), 1 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride, 0.2% Triton X-100, 1 Â protease inhibitor cocktail), washed with phosphate-buffered saline (PBS) and fixed in 100% methanol for 5 min on ice. Immunofluorescence staining was performed by incubating keratinocytes with anti-FANCD2 (Novus, Littleton, CO, USA) or anti-phosphorylated histone H2AX antibody (Upstate, Charlottesville, VA, USA) for 1 h at 37 1C, 5% CO 2 , and then either in polyclonal rhodamine-or monoclonal FITC-conjugated antibodies (Jackson Immunoresearch, West Grove, PA, USA) for 30 min at 37 1C, 5% CO 2 . Vectashield mounting medium with 4,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA, USA) was used for nuclear staining. A Zeiss (Thornwood, NY, USA) Axioplan 2 Imaging microscope and Axiovision Release 4.6 software were used to take images. Keratinocytes containing at least five FANCD2 or gH2AX foci were counted as positive, and the data were expressed as percent positive relative to the total cell number.
Organotypic rafts Tissue sections were deparaffinized with xylene and rehydrated. Following antigen retrieval in 10 mM sodium citrate, sections were blocked with 5% donkey serum (Jackson Immunoresearch) in PBS for 30 min, and then incubated with mouse monoclonal K10 and rabbit polyclonal K14 (both from Covance Research Products, Richmond, CA, USA), mouse monoclonal E-cadherin or mouse monoclonal Ki67 (both from BD Biosciences, San Jose, CA, USA) antiserum in IF antibody dilution buffer (3% bovine serum albumin, 0.5% Triton X-100, 0.05% Tween-20, 0.04% sodium azide in PBS) overnight at 4 1C. Detection was with the abovementioned secondary antibodies (Jackson Immunoresearch) in antibody dilution buffer. BrdU detection was similar using an anti-BrdU antibody (ZBU-30) from Invitrogen (Carlsbad, CA, USA). TUNEL staining was performed using the In situ Cell Death Detection Kit, TMR Red (Roche Applied Science, Indianapolis, IN, USA) as per the manufacturer's instructions. The sections were mounted in Vectashield mounting media containing 4,6-diamidino-2-phenylindole and analysed using the microscope and software described above. To analyse the organotypic raft cultures for the presence of 53BP1 and FANCD2 foci, we used a polyclonal antibody against 53BP1 (Novus Biologicals, Littleton, CO, USA) or FANCD2 (Genetex, San Antonio, TX, USA) followed by a Fluorescein isothiocyanate-or Rhodamine Red-conjugated secondary antibody (Jackson Immunoresearch).
Apoptosis analysis by flow cytometry
Cells were split at a density of 4 Â 10 5 cells per 60 mm dish on feeder fibroblasts, and either left untreated or treated the following day with either 10 or 50 ng/ml MMC (SigmaAldrich). On day 5, cells were trypsinized and 1 Â 10 6 cells from each treatment were washed in 1 Â PBS and fixed for 20 min. Subsequent washes were performed using BD Perm/ Wash Buffer (BD Biosciences). Cells were incubated for 1 h in the dark with 20 ml biotinylated anti-active caspase-3 rabbit monoclonal antibody diluted in 100 ml BD Perm/Wash buffer, followed by a 30 min incubation in 500 ml BD Perm/Wash containing 5 ng of streptavidin-APC (BD Pharmingen, San Jose, CA, USA). Cells were acquired on a BD FACSCalibur instrument (BD Biosciences), and the results were analysed using the FCS3 Express software (De Novo, Los Angeles, CA, USA).
Cell cycle analysis by flow cytometry Cells were split as for the apoptosis assay, but either left untreated or treated on the following day with 0.25 mg/ml melphalan (Sigma-Aldrich). After 48 h, cells were trypsinized and 5 Â 10 5 cells were washed in 1 Â PBS and fixed in 100 ml BD Cytofix/Cytoperm (BD Biosciences). The protocol was followed for the APC BrdU Flow Kit (BD Pharmingen). Cell cycle profiles were detected using 7AAD, with samples acquired on a BD FACSCalibur instrument (BD Biosciences) and the results were analysed using the FCS3 Express software (De Novo).
Western blot analysis
The cells were washed with PBS and whole cell lysates were harvested with RIPA buffer (1% Triton X-100, 1% DOC, 0.1% SDS, 0.16 M NaCl, 10 mM Tris pH 7.4, and 5 mM EDTA) supplemented with a protease inhibitor cocktail (Pharmingen). Protein concentrations were determined using Bradford Reagent (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were boiled in SDS sample buffer and resolved by SDS-polyacrylamide gel electrophoresis. Proteins were transferred to a polyvinylidene difluoride membrane (BioRad) and probed with mouse monoclonal FANCA (5G9, a generous gift from Maureen Hoatlin, OHSU), rabbit polyclonal FANCD2 (Novus Biologicals, Littleton, CO, USA) or an actin-specific monoclonal antibody, a generous gift from James Lessard. On the next day, the membrane was washed with TNET (10 mM Tris, 2.5 mM EDTA, 50 mM NaCl, and 0.1% Tween 20) and secondary anti-mouse or anti-rabbit antibodies conjugated to horseradish peroxidase (Amersham, Piscataway, NJ, USA) were added for 30 min. Membranes were then exposed to enhanced chemilluminescence reagents (Perkin Elmer, Boston, MA, USA) and the protein bands were detected by autoradiography.
Senescence assay
Staining for perinuclear SA-bgal activity was performed as described previously (Dimri et al., 1995) .
